S

Sanbo Hospital Management Group Ltd
SZSE:301293

Watchlist Manager
Sanbo Hospital Management Group Ltd
SZSE:301293
Watchlist
Price: 67.15 CNY -2.92% Market Closed
Market Cap: ¥13.8B

EV/EBIT

92.8
Current
48%
More Expensive
vs 3-y average of 62.8

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
92.8
=
Enterprise Value
¥14.4B
/
EBIT
¥149.2m

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
92.8
=
Enterprise Value
¥14.4B
/
EBIT
¥149.2m

Valuation Scenarios

Sanbo Hospital Management Group Ltd is trading above its 3-year average

If EV/EBIT returns to its 3-Year Average (62.8), the stock would be worth ¥45.43 (32% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-69%
Maximum Upside
No Upside Scenarios
Average Downside
50%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 92.8 ¥67.15
0%
3-Year Average 62.8 ¥45.43
-32%
5-Year Average 62.8 ¥45.43
-32%
Industry Average 29.4 ¥21.29
-68%
Country Average 28.9 ¥20.92
-69%

Forward EV/EBIT
Today’s price vs future ebit

Not enough data available to calculate forward EV/EBIT

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close

Market Distribution

Higher than 82% of companies in China
Percentile
82st
Based on 5 337 companies
82st percentile
92.8
Low
0 — 16.6
Typical Range
16.6 — 52.9
High
52.9 —
Distribution Statistics
China
Min 0
30th Percentile 16.6
Median 28.9
70th Percentile 52.9
Max 49 021

Sanbo Hospital Management Group Ltd
Glance View

Market Cap
13.8B CNY
Industry
Health Care

Sanbo Hospital Management Group Ltd., rooted in the bustling heart of China's healthcare sector, stands as a beacon of modern medical management and innovation. Founded with the mission to address the ever-growing healthcare demands of an expanding urban population, Sanbo has adeptly navigated the complexities of the industry through its impressive network of specialized hospitals and clinics. This enterprise thrives by streamlining hospital operations and fostering an environment where cutting-edge technologies meet compassionate care. By focusing primarily on neurology, a field with increasing incidence and demand globally, Sanbo captures a niche market. Its approach showcases a blend of expertise, employing skilled medical professionals coupled with state-of-the-art medical facilities, thereby enhancing the quality of patient outcomes and drawing a steady stream of clientele. The company's revenue engine hums efficiently by scaling its specialized services and implementing a multi-layered service model. Sanbo generates income through various channels, including direct patient care, diagnostic services, surgical treatments, and long-term patient management programs. Additionally, the firm harnesses strategic partnerships and collaborations with both public and private sectors to expand its reach and improve healthcare accessibility. A notable portion of its revenue also emanates from offering consultancy services to lesser-equipped hospitals looking to optimize their operations. By spearheading initiatives in research and development, Sanbo not only broadens its expertise but also attracts intellectual capital and investments. Each layer of its operations synergistically works to strengthen its foothold in the healthcare market, creating a sustainable model that continues to thrive amidst the evolving medical landscape.

Intrinsic Value
19.75 CNY
Overvaluation 71%
Intrinsic Value
Price ¥67.15
S
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett